Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

Abstract Background Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable to screen for multiple genes simultaneously. The...

Full description

Bibliographic Details
Main Authors: Irene Vanni, Milena Casula, Lorenza Pastorino, Antonella Manca, Bruna Dalmasso, Virginia Andreotti, Marina Pisano, Maria Colombino, Italian Association for Cancer Research (AIRC) Study Group, Ulrich Pfeffer, Enrica Teresa Tanda, Carla Rozzo, Panagiotis Paliogiannis, Antonio Cossu, Paola Ghiorzo, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Diagnostic Pathology
Subjects:
Melanoma
Gene panel testing
Next generation sequencing (NGS)
Somatic mutations
Quality controls
BRAF
Online Access:https://doi.org/10.1186/s13000-020-01052-5

Internet

https://doi.org/10.1186/s13000-020-01052-5

Similar Items